Search for Clinical Trial Results
Metal Metabolism, Inborn Errors - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Health Burden of Hypophosphatasia Condition: Hypophosphatasia Date: 2016-04-01 Interventions: Other: no intervention |
Completed |
Study Name: Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan Condition: Hypophosphatasia Date: 2015-08-11 Interventions: Biological: Asfotase Alfa Other Name: Strensiq |
Approved for marketing |
Study Name: Expanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP) Condition: Hypophosphatasia Date: 2015-07-08 Interventions: Biological: asfotase alfa Patients participating in this program will receive 6 mg/kg/week asfotase alfa |
Completed |
Study Name: Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP) Condition: Hypophosphatasia Date: 2015-03-26 Interventions: Drug: Asfotase Alfa (ALXN1215) Other Name: ALXN1215 |
Enrolling by invitation |
Study Name: An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP) Condition: Hypophosphatasia (HPP) Date: 2014-11-26 |
Completed |
Study Name: Burden of Disease in Hypophosphatasia (HPP) Condition: Hypophosphatasia Date: 2014-11-11 |
Recruiting |
Study Name: Natural History Study of Patients With Hypophosphatasia (HPP) Condition: Hypophosphatasia Date: 2014-09-09 |
Completed |
Study Name: Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP) Condition: Hypophosphatasia (HPP) Date: 2014-03-25 |
Completed |
Study Name: A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP) Condition: Hypophosphatasia (HPP) Date: 2011-08-16 |
Completed |
Study Name: Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP) Condition: Hypophosphatasia Date: 2011-07-29 Interventions: Drug: BPS804 |